Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
45
NICE Quote, Financials, Valuation and Earnings
Last price:
$113.20
Seasonality move
:
4.52%
Day range:
$111.30 - $114.42
52-week range:
$99.00 - $180.61
Dividend yield:
0%
P/E ratio:
12.75x
P/S ratio:
2.49x
P/B ratio:
1.81x
Volume:
642K
Avg. volume:
1.1M
1-year change:
-35.48%
Market cap:
$7B
Revenue:
$2.7B
EPS (TTM):
$8.88
Analysts' Opinion
-
Consensus RatingNICE Ltd. (Israel) has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $160.67, NICE Ltd. (Israel) has an estimated upside of 41.96% from its current price of $113.18.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $120.00 representing -6.03% downside risk from its current price of $113.18.
Fair Value
-
According to the consensus of 13 analysts, NICE Ltd. (Israel) has 41.96% upside to fair value with a price target of $160.67 per share.
NICE vs. S&P 500
-
Over the past 5 trading days, NICE Ltd. (Israel) has overperformed the S&P 500 by 2.72% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
NICE Ltd. (Israel) does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
NICE Ltd. (Israel) has grown year-over-year revenues for 37 quarters straight. In the most recent quarter NICE Ltd. (Israel) reported revenues of $735.4M.
Earnings Growth
-
NICE Ltd. (Israel) has grown year-over-year earnings for 15 quarters straight. In the most recent quarter NICE Ltd. (Israel) reported earnings per share of $2.30.
Enterprise value:
6.6B
EV / Invested capital:
1.68x
Price / LTM sales:
2.49x
EV / EBIT:
10.38x
EV / Revenue:
2.28x
PEG ratio (5yr expected):
0.34x
EV / Free cash flow:
9.52x
Price / Operating cash flow:
10.40x
Enterprise value / EBITDA:
8.02x
Gross Profit (TTM):
$1.9B
Return On Assets:
10.81%
Net Income Margin (TTM):
19.5%
Return On Equity:
15.48%
Return On Invested Capital:
13.75%
Operating Margin:
23.15%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $2.3B | $2.6B | $2.9B | $690M | $735.4M | |
| Gross Profit | $1.6B | $1.8B | $1.9B | $460.3M | $491.4M | |
| Operating Income | $400.9M | $512.3M | $637.9M | $142.2M | $170.2M | |
| EBITDA | $574.5M | $709.8M | $825M | $195.2M | $219.4M | |
| Diluted EPS | $4.93 | $6.46 | $8.88 | $1.87 | $2.30 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2B | $2.2B | $2.5B | $2.4B | $1.4B | |
| Total Assets | $4.4B | $4.6B | $4.9B | $5.2B | $5.2B | |
| Current Liabilities | $1B | $1.1B | $1B | $1.4B | $980.2M | |
| Total Liabilities | $1.6B | $1.7B | $1.7B | $1.6B | $1.3B | |
| Total Equity | $2.8B | $2.9B | $3.2B | $3.6B | $3.9B | |
| Total Debt | $510M | $555.7M | $548.9M | $95.2M | $74.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $557.6M | $763.6M | $790.3M | $159M | $191.6M | |
| Cash From Investing | -$27.7M | -$384.3M | -$152.4M | -$149.8M | $197.1M | |
| Cash From Financing | -$244.7M | -$431.4M | -$883.1M | -$86.4M | -$503.9M | |
| Free Cash Flow | $469.6M | $668.3M | $695.3M | $131.7M | $164.5M | |
NICE
Sector
Market Cap
$7B
$52.8M
Price % of 52-Week High
62.67%
59.28%
Dividend Yield
0%
0%
Shareholder Yield
4.6%
--
1-Year Price Total Return
-35.48%
-14.26%
Beta (5-Year)
1.012
0.667
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$109.35
200-day SMA
Sell
Level
$145.00
Bollinger Bands (100)
Sell
Level
114.86 - 145.52
Chaikin Money Flow
Buy
Level
31.1M
20-day SMA
Buy
Level
$107.96
Relative Strength Index (RSI14)
Buy
Level
53.51
ADX Line
Buy
Level
17.34
Williams %R
Sell
Level
-11.0813
50-day SMA
Sell
Level
$118.35
MACD (12, 26)
Sell
Level
-1.68
25-day Aroon Oscillator
Buy
Level
92
On Balance Volume
Neutral
Level
39.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.6164)
Buy
CA Score
(Annual)
Level (0.977)
Buy
Beneish M-Score
(Annual)
Level (-2.6738)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-2.5407)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
NICE Ltd. engages in the provision of enterprise software solutions and services. It operates through the following segments: Customer Engagement, and Financial Crime and Compliance Solutions. The Customer Engagement segment provides suites such as compliance and risk, workforce optimization, operational efficiency, customer experience, and sales and retention. The Financial Crime and Compliance Solutions segment includes embedded-AI solutions that identify risks and help prevent money laundering and fraud, as well as help ensure financial markets compliance in real-time. The company was founded on September 28, 1986 and is headquartered in Raanana, Israel.
Stock Forecast FAQ
In the current month, NICE has received 7 Buy ratings 6 Hold ratings, and 0 Sell ratings. The NICE average analyst price target in the past 3 months is $160.67.
-
Where Will NICE Ltd. (Israel) Stock Be In 1 Year?
According to analysts, the consensus estimate is that NICE Ltd. (Israel) share price will rise to $160.67 per share over the next 12 months.
-
What Do Analysts Say About NICE Ltd. (Israel)?
Analysts are divided on their view about NICE Ltd. (Israel) share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that NICE Ltd. (Israel) is a Sell and believe this share price will drop from its current level to $120.00.
-
What Is NICE Ltd. (Israel)'s Price Target?
The price target for NICE Ltd. (Israel) over the next 1-year time period is forecast to be $160.67 according to 13 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is NICE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for NICE Ltd. (Israel) is a Buy. 7 of 13 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NICE?
You can purchase shares of NICE Ltd. (Israel) via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase NICE Ltd. (Israel) shares.
-
What Is The NICE Ltd. (Israel) Share Price Today?
NICE Ltd. (Israel) was last trading at $113.20 per share. This represents the most recent stock quote for NICE Ltd. (Israel). Yesterday, NICE Ltd. (Israel) closed at $113.18 per share.
-
How To Buy NICE Ltd. (Israel) Stock Online?
In order to purchase NICE Ltd. (Israel) stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get NICE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NICE
Sector
P/E ratio
12.75x
23.92x
PEG ratio
0.34x
0.00x
P/B ratio
1.81x
2.10x
Price / LTM sales
2.49x
1.41x
Growth Metrics
NICE
Sector
Revenue growth
6.59%
6.61%
Earnings growth
23.54%
10.84%
Revenue (5-year growth)
11.79%
4.95%
Earnings forecast
$3.17
$0.13
Profitability
NICE
Sector
Profitability FY 2024
$1.7B
$29.8M
Return on invested capital
13.75%
-0.62%
Return on assets
10.81%
-1.32%
Return on equity
15.48%
0.23%
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Feb
19
Estimated Next Earnings Date
Feb
12
Balance Sheet
NICE
Sector
Total cash
$455.9M
$39.6M
Short term investments
$1.1B
$16.4M
Total assets
$5.3B
$158.9M
Long term debt
$74.1M
$4.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
87
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
60
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
